Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Aggrastat
2. Agrastat
3. L 700,462
4. L 700462
5. L-700,462
6. L-700462
7. L700,462
8. Mk 383
9. Mk-383
10. N-(butylsulfonyl)-o-(4-(4-piperidyl)butyl)-l-tyrosine
11. Tirofiban
12. Tirofiban Hydrochloride Monohydrate
1. Tirofiban Hydrochloride Monohydrate
2. 150915-40-5
3. Tirofiban Hcl
4. Tirofiban Hydrochloride Hydrate
5. Aggrastat
6. Tirofiban (hydrochloride Monohydrate)
7. Tirofiban Hcl Hydrate
8. Tirofiban Hcl Monohydrate
9. 142373-60-2
10. Tirofiban Hydrochloride [usan]
11. Mk-383 Hydrochloride
12. Chebi:9606
13. Mk 383
14. Mk-383
15. 6h925f8o5j
16. L-700,462
17. Ncgc00182085-01
18. L 700462
19. Tirofibanhydrochloridemonohydrate
20. Dsstox_cid_28561
21. Dsstox_rid_82833
22. N-(butylsulfonyl)-4-(4-(4-piperidyl)butoxy)-l-phenylalanine Monohydrochloride Monohydrate
23. Dsstox_gsid_48635
24. Tirofiban Hydrochloride (usan)
25. L-700462
26. L-tyrosine, N-(butylsulfonyl)-o-(4-(4-piperidinyl)butyl)-, Monohydrochloride, Monohydrate
27. N-(butylsulfonyl)-o-(4-piperidin-4-ylbutyl)-l-tyrosine Hydrochloride Monohydrate
28. (2s)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic Acid Hydrochloride Monohydrate
29. (s)-2-(butylsulfonamido)-3-(4-(4-(piperidin-4-yl)butoxy)phenyl)propanoic Acid Hydrochloride Hydrate
30. Cas-150915-40-5
31. Unii-6h925f8o5j
32. Aggrastat (tn)
33. 4-(4-pyridinyl)butanol Hydrochloride
34. Tirofiban, Hydrochloride
35. Schembl41325
36. Chembl3189072
37. Dtxsid5048635
38. Tirofibanhydrochloride Monohydrate
39. Act04424
40. Bcp06919
41. Tox21_112980
42. Mfcd07368623
43. S8594
44. Tox21_112980_1
45. Ccg-222411
46. Cs-0948
47. Tirofiban Hydrochloride [mart.]
48. Tirofiban Hydrochloride [vandf]
49. Ncgc00263584-01
50. (2s)-2-(butylsulfonylamino)-3-[4-[4-(4-piperidyl)butoxy]phenyl]propanoic Acid Hydrochloride Hydrate
51. As-11027
52. Bt164476
53. Hy-17369
54. Tirofiban Hydrochloride Monohydrate- Bio-x
55. Tirofiban Hydrochloride [orange Book]
56. D01029
57. Tirofiban Hydrochloride Monohydrate [mi]
58. 373t602
59. A908673
60. Q-101314
61. Tirofiban Hydrochloride Monohydrate [who-dd]
62. Tirofiban Hydrochloride Monohydrate, >=98% (hplc)
63. Q27108448
64. L-tyrosine, N-(butylsulfonyl)-o-(4-(4-piperidinyl)butyl)-, Hydrochloride, Hydrate (1:1:1)
Molecular Weight | 495.1 g/mol |
---|---|
Molecular Formula | C22H39ClN2O6S |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 14 |
Exact Mass | 494.2217358 g/mol |
Monoisotopic Mass | 494.2217358 g/mol |
Topological Polar Surface Area | 114 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 579 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
Fibrinolytic Agents
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?